French Society of ENT (SFORL) guidelines. Management of acute Bell's palsy
Copyright © 2020 Elsevier Masson SAS. All rights reserved..
AQFThe authors present the guidelines of the French Society of ENT and Head and Neck Surgery (SFORL) regarding the management of Bell's palsy in adults. After a literature review by a multidisciplinary workgroup, guidelines were drawn up based on retrieved articles and group-members' experience, then read over by an independent group to edit the final version. Guidelines were graded A, B, C or "expert opinion" according to decreasing level of evidence. Thorough ENT and neurological clinical examination is recommended in all patients presenting with peripheral facial palsy to confirm diagnosis of Bell's palsy. MRI with gadolinium enhancement should explore the entire course of the facial nerve, if possible within the first month. ENMG should be performed to assess prognosis for recovery. In confirmed Bell's palsy, corticosteroid therapy should be implemented as early as possible (ideally within 72h) at a dose of 1mg/kg/day for 7-10 days. Antiviral therapy should be associated to steroids in patients with severe and early-onset disease and in Ramsay-Hunt syndrome. Isolated antiviral therapy is not recommended. To date, there is no evidence that surgical facial nerve decompression provides benefit.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2020 |
---|---|
Erschienen: |
2020 |
Enthalten in: |
Zur Gesamtaufnahme - volume:137 |
---|---|
Enthalten in: |
European annals of otorhinolaryngology, head and neck diseases - 137(2020), 6 vom: 24. Dez., Seite 483-488 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Fieux, M [VerfasserIn] |
---|
Links: |
---|
Themen: |
AU0V1LM3JT |
---|
Anmerkungen: |
Date Completed 23.09.2021 Date Revised 23.09.2021 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1016/j.anorl.2020.06.004 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM312135173 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM312135173 | ||
003 | DE-627 | ||
005 | 20231225143748.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2020 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1016/j.anorl.2020.06.004 |2 doi | |
028 | 5 | 2 | |a pubmed24n1040.xml |
035 | |a (DE-627)NLM312135173 | ||
035 | |a (NLM)32636146 | ||
035 | |a (PII)S1879-7296(20)30143-5 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Fieux, M |e verfasserin |4 aut | |
245 | 1 | 0 | |a French Society of ENT (SFORL) guidelines. Management of acute Bell's palsy |
264 | 1 | |c 2020 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 23.09.2021 | ||
500 | |a Date Revised 23.09.2021 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Copyright © 2020 Elsevier Masson SAS. All rights reserved. | ||
520 | |a AQFThe authors present the guidelines of the French Society of ENT and Head and Neck Surgery (SFORL) regarding the management of Bell's palsy in adults. After a literature review by a multidisciplinary workgroup, guidelines were drawn up based on retrieved articles and group-members' experience, then read over by an independent group to edit the final version. Guidelines were graded A, B, C or "expert opinion" according to decreasing level of evidence. Thorough ENT and neurological clinical examination is recommended in all patients presenting with peripheral facial palsy to confirm diagnosis of Bell's palsy. MRI with gadolinium enhancement should explore the entire course of the facial nerve, if possible within the first month. ENMG should be performed to assess prognosis for recovery. In confirmed Bell's palsy, corticosteroid therapy should be implemented as early as possible (ideally within 72h) at a dose of 1mg/kg/day for 7-10 days. Antiviral therapy should be associated to steroids in patients with severe and early-onset disease and in Ramsay-Hunt syndrome. Isolated antiviral therapy is not recommended. To date, there is no evidence that surgical facial nerve decompression provides benefit | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Practice Guideline | |
650 | 4 | |a Systematic Review | |
650 | 4 | |a Bell's palsy | |
650 | 4 | |a Drug therapy | |
650 | 4 | |a ENMG | |
650 | 4 | |a Imaging | |
650 | 4 | |a Physical therapy | |
650 | 7 | |a Adrenal Cortex Hormones |2 NLM | |
650 | 7 | |a Antiviral Agents |2 NLM | |
650 | 7 | |a Contrast Media |2 NLM | |
650 | 7 | |a Gadolinium |2 NLM | |
650 | 7 | |a AU0V1LM3JT |2 NLM | |
700 | 1 | |a Franco-Vidal, V |e verfasserin |4 aut | |
700 | 1 | |a Devic, P |e verfasserin |4 aut | |
700 | 1 | |a Bricaire, F |e verfasserin |4 aut | |
700 | 1 | |a Charpiot, A |e verfasserin |4 aut | |
700 | 1 | |a Darrouzet, V |e verfasserin |4 aut | |
700 | 1 | |a Denoix, L |e verfasserin |4 aut | |
700 | 1 | |a Gatignol, P |e verfasserin |4 aut | |
700 | 1 | |a Guevara, N |e verfasserin |4 aut | |
700 | 1 | |a Montava, M |e verfasserin |4 aut | |
700 | 1 | |a Roch, J A |e verfasserin |4 aut | |
700 | 1 | |a Tankéré, F |e verfasserin |4 aut | |
700 | 1 | |a Tronche, S |e verfasserin |4 aut | |
700 | 1 | |a Veillon, F |e verfasserin |4 aut | |
700 | 1 | |a Vergez, S |e verfasserin |4 aut | |
700 | 1 | |a Vincent, C |e verfasserin |4 aut | |
700 | 1 | |a Lamas, G |e verfasserin |4 aut | |
700 | 1 | |a Tringali, S |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t European annals of otorhinolaryngology, head and neck diseases |d 2010 |g 137(2020), 6 vom: 24. Dez., Seite 483-488 |w (DE-627)NLM201398648 |x 1879-730X |7 nnns |
773 | 1 | 8 | |g volume:137 |g year:2020 |g number:6 |g day:24 |g month:12 |g pages:483-488 |
856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.anorl.2020.06.004 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 137 |j 2020 |e 6 |b 24 |c 12 |h 483-488 |